Most Popular
-
1
Now is no time to add pressure on businesses: top executives
-
2
CJ CheilJedang to spur overseas growth with new Hungary, US plants
-
3
Seoul to host winter festival from Dec. 13
-
4
Nationwide rail disruptions feared as union plans strike from Dec. 5
-
5
Blackpink's solo journeys: Complementary paths, not competition
-
6
N. Korea, Russia court softer image: From animal diplomacy to tourism
-
7
Smugglers caught disguising 230 tons of Chinese black beans as diesel exhaust fluid
-
8
[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
-
9
Actor Song Joong-ki welcomes second child in Rome
-
10
Main opposition pushes to ease, not postpone, tax on crypto gains
![[Today’s K-pop] Blackpink’s Jennie, Lisa invited to Coachella as solo acts](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/21/20241121050099_0.jpg&u=20241121172748)
Chinese bio health care companies line up for IPO in Korea
By 황유미Published : Sept. 22, 2016 - 15:27
[THE INVESTOR] Green Source International of China plans to be listed on KOSDAQ early 2017, and will apply for preliminary investigation in November, according to news reports on Sept. 22.
It will join another Chinese bio company Triplex International Biosciences that hopes to go public in the first quarter of 2017.
Established in 1998, Green Source International is headquartered in Hong Kong, and shifted its focus from fish food manufacturing to health supplement business based on jewel orchid, or Anoectochilus Formosanus, and maca. Its revenue last year reached 67 billion won (US$60.63 million) with net profit of 13 billion won.
The lead counsel for the IPO is Shinhan Investment that is also a consultant for Triplex and Chinese rare herb specialist Fujian Jincao Bioengineering Group, which plans to list later next year.
By Hwang You-mee (glamazon@heraldcorp.com)
It will join another Chinese bio company Triplex International Biosciences that hopes to go public in the first quarter of 2017.
Established in 1998, Green Source International is headquartered in Hong Kong, and shifted its focus from fish food manufacturing to health supplement business based on jewel orchid, or Anoectochilus Formosanus, and maca. Its revenue last year reached 67 billion won (US$60.63 million) with net profit of 13 billion won.
The lead counsel for the IPO is Shinhan Investment that is also a consultant for Triplex and Chinese rare herb specialist Fujian Jincao Bioengineering Group, which plans to list later next year.
By Hwang You-mee (glamazon@heraldcorp.com)
![[Today’s K-pop] Babymonster logs 100m views with ‘Drip’ music video](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=642&simg=/content/image/2024/11/22/20241122050051_0.jpg&u=20241122172213)